HALSTEAD MICHAEL (Chief Executive Officer) purchased 145.8% of their position (100K shares) of HELUS PHARMA INC. on the open market
Open‑market purchase worth $1.35M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/21/2026ACC: 0000912282-26-001293
Officer· Chief Executive Officer
Since Sep 2026
+100K
Net shares
Net buyer
$1.35M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+100K
Price / share
$13.47
Trade value
$1.35M
% of position
145.8%
9/21/2026
68.57K→168.57K
Total
Net shares
+100K
Net value
$1.35M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/21/2026 | P · Purchase | +100K | $13.47 | $1.35M | 145.8% | 68.57K | 168.57K |
| Total | +100K | $1.35M | ||||||
Derivative Transactions0
No derivative transactions reported